UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
_________________________________
FORM i 8-K
_________________________________
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): i March 5, 2020 _________________________________
i AmerisourceBergen
Corporation
(Exact name of registrant as specified in its charter)
_________________________________
Commission File Number: i 1-6671
|
| | | | |
i Delaware | | i 23-3079390 |
(State
or other jurisdiction of | | (I.R.S. Employer |
incorporation or organization) | | Identification No.) |
| | | | |
i 1300
Morris Drive | | | | |
(Address
of principal executive offices) | | (Zip Code) |
( i 610) i 727-7000
(Registrant’s telephone number, including area code)
Not
Applicable
(Former name or former address, if changed since last report.)
Securities registered pursuant to Section 12(b) of the Act:
|
| | | |
Title of each class | Trading Symbol(s) | Name of exchange on which registered |
i Common
stock | i ABC | i New York Stock Exchange | (NYSE) |
_________________________________
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
i ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
i ☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
i ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
i ☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company i ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o
Item
5.07. Submission of Matters to a Vote of Security Holders.
(b) Each of the five items listed below was submitted to a vote of the Company's stockholders at the 2020 Annual Meeting and is described in more detail in the definitive proxy statement filed by the Company with the Securities and Exchange Commission on January
24, 2020 (the "Definitive Proxy Statement"). The final voting results are below:
Item 1 - Election of Directors.
Each of the individuals listed below was elected by the Company's stockholders to serve as a director until the 2021 annual meeting of stockholders and until his or her successor is duly elected and qualified. |
| | | | | | | | | |
Nominees | | For | | Against | | Abstentions | | Broker Non-Votes | |
Ornella
Barra | | 175,515,019 | | 4,631,277 | | 157,026 | | 11,288,046 | |
Steven H. Collis | | 170,606,516 | | 9,118,618 | | 578,188 | | 11,288,046 | |
D.
Mark Durcan | | 179,842,980 | | 313,691 | | 146,651 | | 11,288,046 | |
Richard W. Gochnauer | | 175,196,214 | | 4,933,502 | | 173,606 | | 11,288,046 | |
Lon
R. Greenberg | | 179,679,352 | | 476,339 | | 147,631 | | 11,288,046 | |
Jane E. Henney, M.D. | | 171,241,347 | | 8,910,415 | | 151,560 | | 11,288,046 | |
Kathleen
W. Hyle | | 179,617,270 | | 529,579 | | 156,473 | | 11,288,046 | |
Michael J. Long | | 165,763,361 | | 14,385,707 | | 154,254 | | 11,288,046 | |
Henry
W. McGee | | 171,701,593 | | 8,440,871 | | 160,858 | | 11,288,046 | |
Dennis M. Nally | | 179,896,872 | | 258,951 | | 147,499 | | 11,288,046 | |
Item
2- Ratification of Appointment of Ernst & Young LLP as the Company's Independent Registered Public Accounting Firm for Fiscal Year 2020.
The Company's stockholders approved this item. The voting results are as follows: |
| | | | | | | |
For | | Against | | Abstentions | | | |
184,687,448 | | 6,802,088 | | 101,832 | | | |
Item
3 - Advisory Vote to Approve the Compensation of the Company's Named Executive Officers.
The Company's stockholders approved this item. The voting results are as follows: |
| | | | | | | |
For | | Against | | Abstentions | | Broker Non-Votes | |
170,608,974 | | 9,516,495 | | 177,853 | | 11,288,046 | |
Item
4 - Stockholder Proposal to Permit Action by Written Consent of the Stockholders.
The Company's stockholders did not approve this item. The voting results are as follows: |
| | | | | | | |
For | | Against | | Abstentions | | Broker Non-Votes | |
62,358,616 | | 117,691,617 | | 253,089 | | 11,288,046 | |
Item
5 - Stockholder Proposal Regarding the Use of a Deferral Period for Certain Compensation of Senior Executives.
The Company's stockholders did not approve this item. The voting results are as follows: |
| | | | | | | |
For | | Against | | Abstentions | | Broker Non-Votes | |
61,197,092 | | 114,468,371 | | 4,637,859 | | 11,288,046 | |
No
item other than the five items addressed above and described in the Definitive Proxy Statement was submitted at the 2020 Annual Meeting for stockholder action.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
| | | |
| | AMERISOURCEBERGEN
CORPORATION |
| | | |
Date: | | By: | |
| | Name: | |
| | Title: | Executive Vice President, Chief Legal Officer and Secretary |
